Milestone Pharmaceuticals Inc. is a strong buy after a 37% drop post-Cardamyst FDA approval. Click for this updated look at ...

Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

A federal appeals court granted Express Scripts Inc. ‘s petition for a jury trial in a case from 120 cities, towns, and counties across West Virginia alleging the company played a central role in the ...

“The Seventh Amendment entitles litigants to a jury trial unless the claim would have been heard, and the remedy awarded, by courts of equity at the Founding," Judge Julius Richardson wrote for the ...

Milestone Pharmaceuticals (NASDAQ:MIST) said its first quarter of 2026 marked the beginning of commercial sales for CARDEMYST, its newly approved treatment for acute episodes of paroxysmal ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The dispute centers on ...

Charter has taken Express Scripts to court, accusing the pharmacy-benefit manager of holding back millions in drug rebate payments tied to prescription claims from 2020 through 2022. The complaint, ...

JOHNSTOWN, Pa. (WTAJ) — Thousands of patients are still separated from a community pharmacy chain in Cambria, Somerset and Westmoreland counties after a 2025 decision by a global health company left ...

The Federal Trade Commission’s Feb.4 consent order with Express Scripts represents the most consequential structural overhaul of the pharmacy benefit manager industry to date. Policymakers and ...

Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...